The measure addresses adherence to angiotensin converting enzyme inhibitors (ACEIs)/angiotensin receptor blockers (ARBs). The measure is reported as the percentage of eligible individuals with diabetes mellitus who had at least two prescriptions for ACEIs/ARBs and who have a Proportion of Days Covered (PDC) of at least 0.8 during the measurement period (12 consecutive months).
Individuals in the denominator with at least two prescriptions for ACEIs/ARBs with a PDC of at least 0.8 for ACEIs/ARBs.
Denominator
1.15 Denominator
Individuals at least 18 years of age as of the beginning of the measurement period with diabetes mellitus and at least two prescriptions for ACEIs/ARBs during the measurement period (12 consecutive months).
Exclusions
Exclusions
We excluded the following individuals from the denominator: Individuals with polycystic ovaries, gestational diabetes, or steroid-induced diabetes who do not have a face-to-face visit with a diagnosis of diabetes in any setting during the measurement period. Exclusion 1 Individuals with a diagnosis of polycystic ovaries who do not have a visit with a diagnosis of diabetes in any setting during the measurement period*; and,
Exclusion 2 Individuals with a diagnosis of gestational diabetes or steroid-induced diabetes who do not have a visit with a diagnosis of diabetes mellitus in any setting during the measurement period.
*Adapted from NCQA HEDIS 2013 (2013). Note: HEDIS uses a look-back period of one year prior to the measurement period for both the prescription data and diagnosis.
Measure Record
Most Recent Endorsement Activity
Measure Retired and Endorsement Removed Primary Care and Chronic Illness Spring Cycle 2018
Initial Endorsement
Last Updated
Removal Date
Point of Contact
Steward Organization
Centers for Medicare & Medicaid Services
Steward POC email
Helen.Dollar-Maples@cms.hhs.gov
Steward Organization Copyright
Limited proprietary coding is contained in the measure specifications for user convenience. Use of these codes may require permission from the code owner or agreement to a license.
Public Comments